Three child silhouettes on white background

92% of Foster Care Kids Using Psychotropic Meds Get Them For Unacceptable Reasons

From the Washington Post yesterday, most foster care children on antipsychoctic drugs get them for far too long and without medical justification. 2/3 of the nearly 700 claims studied raised high-risk “quality of care” issues. As a long time CASA volunteer guardian ad-Litem, many of my case kids were on multiple drugs simultaneously and many of them hated being forced to use them. Some kids threw the drugs away.

In Minneapolis, I would like to know (there should be more transparency) if six year old Kendrea Johnson’s suicide by hanging involved psychotropic medications. She was a very troubled foster child, in therapy and had talked about homicide and suicide. When Jeff Weise killed himself, his grandfather and 14 others he had talked about suicide and homicide and was taking Prozac.

7 year old foster child Gabriel Myers hung himself and left a note about how he hated Prozac. KARA’s video interviews include families, a City Councilman, and other professionals talking about antipsychotic medications, very young children and suicide. This subject needs our attention now. It is cruel punishment for a child suffering from the traumas of abuse and removal from a birth home to be dealt with.

There are 3 children’s hospitals in the metro area and NO children’s mental health hospitals and there are 800 to 1000 emergency psychiatric visits at HCMC every month (many of them children).

This conversation is overdue.

What we don’t know cannot be dealt with and will not be improved. Let’s stop the next awful six year old suicide.

Close-up bright green caterpillar on twig

Help KARA Do Something About Drugging Foster Kids (invitation to action)

Invisible Children readers know that psychotropic medications, especially “antipsychotics,” often are used to sedate and restrain problematic people, children especially—and not just any children, but foster children particularly, and most of all, foster children in so-called “group homes.”

Agreement is widespread that foster kids are over-medicated: too many, too young, too many drugs per child, on dosages that are too high and are maintained too long, often for years on end.

The PsychDrugs Action Campaign of the National Center for Youth Law invites you to help make positive changes now. Our contact information is at the bottom of this message.

Why Foster Children?

Foster children are a lucrative market for psychotropic drug sales. Unlike adults, they can’t say “no, I won’t take any more.” Their parents are in no position to object. Responsibility for prescribing is diffused confusingly among foster parents, caseworkers, child welfare supervisors, group home administrators, and prescribers. All are involved, but their roles in medication decisions are overlapping and ill-defined. It is easy for each to say, “it wasn’t my decision.”

One of the consequences is that in some states about half of children in group homes are medicated with psychotropic drugs. Many foster children are dozing through their childhoods and teenage years in a semi-sedated fog, a fog that is profitable for the drug industry and convenient for those administrators, staff, and foster parents who prefer to minimize demands on their time and attention.

The losers are the kids. A dozen years in a chemical straitjacket is no preparation for adult independence.

Silhouettes of a family with two adults and one child.

Mass Psychosis in the U.S – Important Insights Into Big Pharma, Psychotropics, & Children

Marcia Angell, former editor of the New England Journal of Medicine and a leading critic of the Big Pharma, puts it more bluntly: “Psychiatrists are in the pocket of industry.” Angell has pointed out that most of the Diagnostic and Statistical Manual of Mental Disorders (DSM), the bible of mental health clinicians, have ties to the drug industry. Likewise, a 2009 study showed that 18 out of 20 of the shrinks who wrote the American Psychiatric Association’s most recent clinical guidelines for treating depression, bipolar disorders, and schizophrenia had financial ties to drug companies.